14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Wednesday, 24th Apr 2024 ALNY stock ended at $143.80. This is 1.55% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.76% from a day low at $143.52 to a day high of $147.49.
90 days $143.51 $188.69
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Oct 29, 2020 $124.93 $125.38 $121.56 $123.32 536 029
Oct 28, 2020 $125.59 $126.85 $123.24 $124.88 444 253
Oct 27, 2020 $128.52 $130.88 $126.07 $126.82 488 221
Oct 26, 2020 $130.08 $132.00 $126.71 $128.67 451 019
Oct 23, 2020 $134.75 $134.75 $130.72 $131.84 525 507
Oct 22, 2020 $136.49 $140.66 $133.77 $134.30 480 052
Oct 21, 2020 $141.36 $143.41 $135.93 $136.48 359 263
Oct 20, 2020 $141.92 $143.51 $140.41 $141.45 346 739
Oct 19, 2020 $144.94 $145.40 $139.53 $140.64 502 089
Oct 16, 2020 $144.12 $148.07 $144.12 $145.40 327 701
Oct 15, 2020 $142.52 $145.72 $141.30 $143.94 277 087
Oct 14, 2020 $147.36 $147.99 $143.86 $143.91 251 356
Oct 13, 2020 $147.00 $148.74 $144.76 $146.66 257 495
Oct 12, 2020 $148.00 $148.05 $145.09 $147.00 313 612
Oct 09, 2020 $145.86 $147.98 $145.19 $147.00 275 481
Oct 08, 2020 $146.80 $147.76 $144.81 $146.04 228 212
Oct 07, 2020 $144.03 $146.50 $142.58 $145.40 366 360
Oct 06, 2020 $142.01 $146.77 $142.01 $143.26 364 537
Oct 05, 2020 $136.29 $142.27 $136.29 $142.00 470 009
Oct 02, 2020 $141.84 $143.72 $135.24 $135.68 613 688
Oct 01, 2020 $146.70 $148.76 $143.30 $143.74 558 766
Sep 30, 2020 $144.17 $147.00 $142.37 $145.60 535 792
Sep 29, 2020 $140.00 $145.25 $138.66 $145.01 501 686
Sep 28, 2020 $139.16 $140.00 $137.17 $139.81 327 870
Sep 25, 2020 $134.13 $138.80 $132.37 $138.31 607 020
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT